Co-Infusion of Mesenchymal Stromal Cells to Prevent GVHD After Allogeneic Hematopoietic Cell Transplantation from HLA-Mismatched Unrelated Donors After Reduced-Intensity Conditioning: A Double-Blind Randomized Study and Literature Review

Scientists established a multicenter, prospective, randomized, double-blind trial evaluating the efficacy of co-infusing third-party mesenchymal stromal cells versus placebo on the day of hematopoietic stem cell transplantation to prevent graft-versus-host disease (GVHD) in recipients of HLA-mismatched unrelated donors after reduced-intensity conditioning.